GAINESVILLE, FL. (February 15, 2024) – etectRx, a leading innovator in digital health sensor solutions, proudly announces the appointment of Scott Kozimor as Vice President of Sales. With an illustrious career spanning over two decades in...
Read more
The ID-Cap™ System embarks on a promising journey in 2024, receiving continued praise from clinical trials. Researchers from Brigham and Women’s Hospital and Ohio State University welcomed the new year in sunny Honolulu to present...
Read more
The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication non-adherence. Medication nonadherence is a widespread problem, resulting in...
Read more
University of Cape Town announces ID-Cap™ System acceptability study in South Africa. Mass General Brigham in collaboration with University of Cape Town is conducting a new research study to assess the feasibility and acceptability of a...
Read more
etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in Adults living with HIV (QUANTI-TAF) study...
Read more
NCT03512418- An ongoing study designed to evaluate PrEP adherence data using cognitive behavioral therapy based interventions delivered through the ID-Cap™ System in MSM (men who have sex with men) participants with substance abuse who receive oral PrEP (HIV pre-exposure prophylaxis). Early trial results from 10 pilot study subsample participants demonstrate the effectiveness of intervention messages following
